BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23815127)

  • 1. Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.
    Frasconi M; Liu Z; Lei J; Wu Y; Strekalova E; Malin D; Ambrogio MW; Chen X; Botros YY; Cryns VL; Sauvage JP; Stoddart JF
    J Am Chem Soc; 2013 Aug; 135(31):11603-13. PubMed ID: 23815127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
    Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles functionalised with a photoactive ruthenium(ii) complex: exploring the formulation of a metal-based photodynamic therapy photosensitiser.
    Ellahioui Y; Patra M; Mari C; Kaabi R; Karges J; Gasser G; Gómez-Ruiz S
    Dalton Trans; 2019 May; 48(18):5940-5951. PubMed ID: 30209497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes.
    Shi H; Lou J; Lin S; Wang Y; Hu Y; Zhang P; Liu Y; Zhang Q
    J Inorg Biochem; 2021 Aug; 221():111489. PubMed ID: 34000586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
    Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
    Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
    Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
    Barkat A; Beg S; Panda SK; S Alharbi K; Rahman M; Ahmed FJ
    Semin Cancer Biol; 2021 Feb; 69():365-375. PubMed ID: 31442571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
    Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
    Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
    Qu Q; Ma X; Zhao Y
    ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
    Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
    Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer.
    Pallares RM; Agbo P; Liu X; An DD; Gauny SS; Zeltmann SE; Minor AM; Abergel RJ
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40078-40084. PubMed ID: 32805833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
    Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
    ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional material based on ionic transition metal complexes and gold-silica nanoparticles: synthesis and photophysical characterization for application in imaging and therapy.
    Ricciardi L; Martini M; Tillement O; Sancey L; Perriat P; Ghedini M; Szerb EI; Yadav YJ; La Deda M
    J Photochem Photobiol B; 2014 Nov; 140():396-404. PubMed ID: 25317968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.